Prespecified subgroup analysis of placebo-controlled Phase-III Trial (TEMSO) of Teriflunamide in relapsing multiple sclerosis

Christian Confavreux, Ludwig Kappos, Tomas P Olsson, Philippe Truffinet, Lin Wang, Laura D’Castro, Giancarlo Comi, Mark S Freedman, The Teriflunamide Trial Multiple Sclerosis Trial Group, Egon Stenager (Medlem af forfattergruppering)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftMultiple Sclerosis Journal
Vol/bind18
Udgave nummer11
Sider (fra-til)1625-32
ISSN1352-4585
DOI
StatusUdgivet - 2013

Citationsformater

Confavreux, C., Kappos, L., Olsson, T. P., Truffinet, P., Wang, L., D’Castro, L., Comi, G., Freedman, M. S., The Teriflunamide Trial Multiple Sclerosis Trial Group, & Stenager, E. (2013). Prespecified subgroup analysis of placebo-controlled Phase-III Trial (TEMSO) of Teriflunamide in relapsing multiple sclerosis. Multiple Sclerosis Journal, 18(11), 1625-32. https://doi.org/10.1177/1352458512450354